Type 2 diabetes – canagliflozin, dapaglifozin and empaglifozin as monotherapies

This is new guidance from NICE advising that canagliflozin, dapagliflozin and empagliflozin can all be used as monotherapies in treating Type 2 Diabetes. Previously they have only been advised as add-...